Literature DB >> 16938516

The value of MDM2 and CDK4 amplification levels using real-time polymerase chain reaction for the differential diagnosis of liposarcomas and their histologic mimickers.

Shio Shimada1, Takashi Ishizawa, Keisuke Ishizawa, Tadaki Matsumura, Tadashi Hasegawa, Takanori Hirose.   

Abstract

Atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL) and dedifferentiated liposarcoma (DDL) are reported to have murine double-minute type 2 (MDM2) and cyclin-dependent kinase 4 (CDK4) amplification as a characteristic genetic alteration. To evaluate the diagnostic utility of this gene abnormality, we analyzed 19 liposarcomas, 21 malignant fibrous histiocytomas, 3 leiomyosarcomas, 5 malignant peripheral nerve sheath tumors, 23 lipomas, and 28 nonneoplastic fat tissues using real-time polymerase chain reaction (PCR) and fluorescence in situ hybridization (FISH). In real-time PCR, all ALT/WDLs and DDLs had both MDM2 and CDK4 amplifications. The amplification levels in ALT/WDLs and DDLs were significantly higher than those in the other sarcomas, lipomas, and nonneoplastic fat tissues (P < .05); however, those in the other sarcomas and lipomas were not significantly higher than those in nonneoplastic tissues. In FISH, all ALT/WDLs and DDLs had both MDM2 and CDK4 amplifications, and all of the myxoid/round cell liposarcomas, leiomyosarcomas, malignant peripheral nerve sheath tumors, and all but one of the malignant fibrous histiocytomas did not have the amplifications. In this study, MDM2 and CDK4 amplifications were confirmed in ALT/WDLs and DDLs, and the amplification levels were significantly higher than those in the other tumors. An analysis of MDM2 and CDK4 amplification using real-time PCR, as well as FISH, is useful for the differential diagnosis of liposarcomas and their histologic mimickers.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16938516     DOI: 10.1016/j.humpath.2006.04.010

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  20 in total

1.  Utility of fluorescence in situ hybridization to detect MDM2 amplification in liposarcomas and their morphological mimics.

Authors:  Hiroaki Kimura; Yoh Dobashi; Takayuki Nojima; Hiroyuki Nakamura; Norio Yamamoto; Hiroyuki Tsuchiya; Hiroko Ikeda; Seiko Sawada-Kitamura; Takeru Oyama; Akishi Ooi
Journal:  Int J Clin Exp Pathol       Date:  2013-06-15

Review 2.  Update on genomic and molecular landscapes of well-differentiated liposarcoma and dedifferentiated liposarcoma.

Authors:  Jun Lu; David Wood; Evan Ingley; Sulev Koks; Daniel Wong
Journal:  Mol Biol Rep       Date:  2021-04-24       Impact factor: 2.316

3.  Rare synchronous primary large B-cell gastric lymphoma and huge retroperitoneal liposarcoma with inguinal hernia in chronic hepatitis B patient.

Authors:  P Ghimire; G Y Wu; L Zhu
Journal:  Curr Oncol       Date:  2011-04       Impact factor: 3.677

4.  Liposarcomas of the posterior mediastinum: clinicopathologic study of 18 cases.

Authors:  Pablo Ortega; David Suster; Giovanni Falconieri; Eduardo Zambrano; Cesar A Moran; Carl Morrison; Saul Suster
Journal:  Mod Pathol       Date:  2014-12-05       Impact factor: 7.842

Review 5.  The Role of MDM2 Amplification and Overexpression in Tumorigenesis.

Authors:  Jonathan D Oliner; Anne Y Saiki; Sean Caenepeel
Journal:  Cold Spring Harb Perspect Med       Date:  2016-06-01       Impact factor: 6.915

6.  Genomic and clinical analyses of 2p24 and 12q13-q14 amplification in alveolar rhabdomyosarcoma: a report from the Children's Oncology Group.

Authors:  Frederic G Barr; Fenghai Duan; Lynette M Smith; Donna Gustafson; Mandy Pitts; Sue Hammond; Julie M Gastier-Foster
Journal:  Genes Chromosomes Cancer       Date:  2009-08       Impact factor: 5.006

7.  MRI characteristics of lipoma and atypical lipomatous tumor/well-differentiated liposarcoma: retrospective comparison with histology and MDM2 gene amplification.

Authors:  Mélanie Brisson; Takeshi Kashima; David Delaney; Roberto Tirabosco; Andrew Clarke; Suzie Cro; Adrienne M Flanagan; Paul O'Donnell
Journal:  Skeletal Radiol       Date:  2012-09-18       Impact factor: 2.199

Review 8.  Genetic aberrations in soft tissue leiomyosarcoma.

Authors:  Jilong Yang; Xiaoling Du; Kexin Chen; Antti Ylipää; Alexander J F Lazar; Jonathan Trent; Dina Lev; Raphael Pollock; Xishan Hao; Kelly Hunt; Wei Zhang
Journal:  Cancer Lett       Date:  2008-07-22       Impact factor: 8.679

Review 9.  Pancreatic solid cystic desmoid tumor: case report and literature review.

Authors:  Bin Xu; Ling-Hua Zhu; Jia-Guo Wu; Xian-Fa Wang; Erik Matro; Jun-Jun Ni
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

Review 10.  Systemic treatment of soft-tissue sarcoma-gold standard and novel therapies.

Authors:  Mark Linch; Aisha B Miah; Khin Thway; Ian R Judson; Charlotte Benson
Journal:  Nat Rev Clin Oncol       Date:  2014-03-18       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.